Literature DB >> 6856990

Duration of immunity and absorption of cysticerci in calves after treatment of Taenia saginata cysticercosis with praziquantel.

G J Gallie, M M Sewell.   

Abstract

Calves were first infected with 5000 Taenia saginata eggs at six to 10 weeks old and treated with praziquantel 12 weeks later. Complete immunity against challenge lasted for at least 12 weeks following anthelmintic treatment. Six months after drug treatment over 90 per cent of the cysticerci had been completely absorbed but some were still detectable especially in the heart. An increase was observed in the ELISA values of sera from infected calves following treatment with praziquantel, but no such rise was detected in sera from resistant calves after challenge infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6856990

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  4 in total

Review 1.  Studies on helminthosis at the Centre for Tropical Veterinary Medicine (CTVM).

Authors:  L J Harrison; J A Hammond; M M Sewell
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

2.  Control of Taenia saginata by post-mortem examination of carcasses.

Authors:  W Wanzala; J A Onyango-Abuje; E K Kang'ethe; K H Zessin; N M Kyule; M P O Baumann; H Ochanda; L J S Harrison
Journal:  Afr Health Sci       Date:  2003-08       Impact factor: 0.927

Review 3.  Human taeniasis: current insights into prevention and management strategies in endemic countries.

Authors:  Anna L Okello; Lian Francesca Thomas
Journal:  Risk Manag Healthc Policy       Date:  2017-06-01

4.  Efficacy of a single dose of milbemycin oxime/praziquantel combination tablets, Milpro(®), against adult Echinococcus multilocularis in dogs and both adult and immature E. multilocularis in young cats.

Authors:  Dejan Cvejic; Claudia Schneider; Josephus Fourie; Christa de Vos; Stephane Bonneau; Natalia Bernachon; Klaus Hellmann
Journal:  Parasitol Res       Date:  2015-12-11       Impact factor: 2.289

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.